Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06130254
Status:
RECRUITING
Last Update Posted:
2024-04-16
First Post:
2023-11-08
Brief Title:
Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib MRTX849 in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors With a Focus on Gynecological Breast Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-30
Start Date Type:
ACTUAL
Primary Completion Date:
2028-08-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-08-25
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-08
First Submit QC Date:
November 8 2023
Study First Post Date:
2023-11-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-15
Last Update Post Date:
2024-04-16
Last Update Post Date Type:
ACTUAL